Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Deucravacitinib effectively treats psoriasis and may help with other skin conditions.

Regulatory T cells are essential for normal and improved wound healing in mice.

Ritlecitinib shows promise in improving severe alopecia areata, with 27% of patients seeing success.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

High TNF-α levels may increase hair loss risk after PRP therapy.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

The effectiveness of statins for women with PCOS is unclear.

Testosterone reduces heart damage and inflammation after injury.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Cepharanthine can block enterovirus entry and protect against infection.

Corticosteroids regrow hair better and faster than pentoxifylline for alopecia areata.

Tralokinumab may help improve symptoms of atopic dermatitis and alopecia areata.

Lotion with piroctone olamine and triclosan improves hair loss in men.

Systemic retinoids do not increase COVID-19 risk or severity.

Spironolactone helps reduce fluid in the eye in Central Serous Chorioretinopathy, but doesn't improve vision and recurrence is common.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

A new mutation in the TRPS1 gene caused Trichorhinophalangeal syndrome in a 17-year-old, highlighting the need for genetic testing.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Ritlecitinib effectively regrows hair in treatment-resistant alopecia areata with mild side effects.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.